CLINICAL_TRIALS
trial_result
· 2020-10-08
Clinical Trial Update: D-serine and Cognitive Remediation in Schizophrenia [Phase 2]
Summary
Phase 2 clinical trial evaluating D-serine with cognitive remediation in schizophrenia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2020-10-08